Filed · Dallas Division

Healthcare deals,
handled by an operator.
Not a broker dressed as one.

JKMG Group is a Dallas-based healthcare brokerage and strategic advisory firm. We work sell-side, buy-side, recap, and advisory across pharmacy, physician practices, senior care, laboratories, and licensed agencies. Engagements are run by the CEO/Founder, who built and sold healthcare companies before he ever sold someone else's.

Pharmacy

  • Retail
  • Compound
  • Specialty Infusion

Physician Practices

  • PodiatryDFW
  • Primary CareDFW
  • Internal MedicineDFW
  • CardiologyDFW
  • Eye PracticesTX / US two or more doctors

Senior Care

  • Assisted LivingDFW
  • Skilled NursingTX single location

Laboratories

  • PathologyUS
  • Path · PCRUS

Agencies · TX

  • Home Health
  • Hospice
  • DME
Or license-only
§ 01 · Practice

The practice, plainly stated.

Primary · Adjacent
§ 01.APrimary Practice

Healthcare Brokerage.

What JKMG Group is built to do.

End-to-end transaction work for founder-led healthcare companies. We position the asset, qualify the right buyers, run a real process, and protect the operator through close and after.

Brokerage is the practice. Every other thing the firm offers either feeds into a transaction or grows out of one. If you're a founder thinking about a sale, a recap, or a buy-side platform build, this is the door.

Engagements are run by the CEO/Founder. No associates fronting senior calls, no farmed-out diligence, no surprise team swap after the LOI.

Sell-sideStrategic and sponsor buyer universes, run as a real process with parallel tracks.
Buy-sidePlatform searches and add-on acquisitions for sponsor-backed operators.
RecapPartial liquidity structuring that keeps the operator in the chair.
Quality of EarningsPrepared alongside accounting partners before buyers ask.
Post-LOIDiligence response, close mechanics, transition planning.
§ 01.B · Adjacent Practice

Strategic Consulting.

For companies not ready for a transaction, or not interested in one. We advise on operating posture, growth thesis, and the value-creation work that makes a future transaction credible. This is a smaller line of work than the brokerage, and it's usually engaged 12 to 24 months ahead of any process.

Typical work: strategic advisory to vascular, lab, and house-call companies · operating diagnostics · growth thesis and capital posture · board-level counsel for founders and physician-owners.

§ 02 · Active Mandates

On the desk, now.

Live · Anonymized

A working slice of what the desk is carrying. Mandates are anonymized by design — books, financials, and process phase open under signed NDA. Inventory rotates as transactions close, so what's listed here reflects only what's currently in market.

11
Active mandates
~$56M
Aggregate enterprise value
$200K–$20M
Engagement range
M-01 Active

Family Practice

Flower Mound, TX
$1.4M
M-02 Active

PCR Lab

Frisco, TX
$9M
M-03 Active

RPM Software Company

Healthcare SaaS
$1.1M
M-04 Active

Wound-Graft Clinical Research

DFW, TX
$500K
M-05 Active

Hospice

Texas
$10M
M-06 Active

Optometry Practice

Frisco, TX
$425K
M-07 Active

Family Practice

Denton, TX
$2.7M
M-08 Active

Assisted Living Facility

Garland, TX
$8M
M-09 Active

Medical Land

Frisco, TX
$2.2M
M-10 Active

Two Small PCR Labs

Houston · Dallas, TX
$200Keach
M-11 Active

Toxicology Lab

Los Angeles, CA
$20M
Request · By NDA

The current book.

Teasers, financials, location detail, process phase — for the right buyer or operator only. The desk reads every note.
Reach §06 →
Specifics — teaser, financials, location detail, current process phase — released under signed NDA. To request the current book or to be added to a buy-side track for a specific asset class, reach the desk at §06 Engage.
§ 03 · Engagement Sequence

How a JKMG engagement actually runs.

Phase / Focus / Output
01 / Intake
Direct call with the CEO/Founder. We listen first, ask sharp questions, and confirm whether the work makes sense for both sides. No associates fronting senior calls. No vague second-meeting handoffs.
Engagement decision
02 / Readiness
Prepare the asset honestly. Financials normalized, story tightened, weaknesses documented before a buyer's diligence team finds them. The goal is no surprises in the second meeting.
Diligence-ready package
03 / Mapping
The right buyer is rarely the loudest one. We map strategics, sponsors, and platform owners against the operator's actual goals — not just the highest theoretical multiple.
Targeted buyer universe
04 / Process
A real process: managed correspondence, controlled diligence, paced negotiation. The seller talks to buyers when it matters, not at every step. We absorb the volume; you stay on the practice.
Competitive offers
05 / Close & After
Closing rooms are predictable when the process was real. After the close, the desk stays reachable. Most founders call back a year later about what comes next — and we like that.
Closed transaction
Specialty-specific timing varies. Sell-side mandates in physician practice and pharmacy typically run six to ten months from intake to close; recap and advisory engagements run on their own clock. The process is consistent. The pace is not.
§ 04 · Network

A network of operators who introduce well.

By invitation
Tiered Member Network

An invitation-based circle of physicians, advisors, and operators who refer the firm to the right founders at the right time.

The network is small. Members are people we trust to recognize a good practice when they see one, and to introduce us thoughtfully. In return, members move through four tiers (Entry Level, Growth, Strategic, Elite) with structured recognition for the quality and consistency of their referrals.

§ 05 · CEO · Founder

An operator first. A broker second.

On file at JKMG Group
Portrait of Michael G. Morales, CEO and Founder of JKMG Group
Of RecordCEO · Founder
DeskDallas, TX
PracticeHealthcare M&A
ClassND '00 · LBJ '96

Michael G. Morales

CEO · Founder · Managing Director

Mr. Morales is an accomplished business owner who has guided his companies through due diligence and capital-raising processes with investors, attorneys, family offices, and private equity firms. With over twenty years of expertise in healthcare management, strategic consulting, financial analysis, and compliance, he delivers tailored solutions to corporations, healthcare organizations, and their advisors.

His background as a healthcare company owner, not merely an advisor to one, enables him to support every stage of a transaction or strategic engagement: operational diagnostics, valuation, deal structuring, post-close governance, and strategic advisory. Whether the engagement is brokerage or board-level counsel, Mr. Morales draws on the operating experience that built the firms he now sells and advises.

In 2018 he was the first user provisioned on Oracle Autonomous Database, and opened Oracle OpenWorld that year as the warm-up speaker for Larry Ellison. Healthcare wasn't always the obvious through-line, but the operator's habit of building things that have to actually work was.

He has founded multiple healthcare companies, several of which he later sold, and continues to serve as strategic advisor to vascular, laboratory, and physician house-call companies.

Education · Undergrad
University of Notre Dame · 2000
B.S., Science Pre-Professional · Minor, Anthropology
Education · Secondary
LBJ HS Science Academy · 1996
Class President
Industry Footprint
Founded multiple healthcare companies
Several sold; advisory roles ongoing
Notable
Oracle OpenWorld 2018 · opening speaker
First provisioned user, Oracle Autonomous DB
§ 06 · Engage

Tell the desk what you're working on.

Reviewed personally by the CEO/Founder

Every inquiry routes to the CEO/Founder first. We don't gatekeep through associates. If a call makes sense, you'll hear back as soon as the desk reviews it.

If you're a founder considering a sale or recap, start here. If you're a sponsor or strategic with an active mandate, also here. If you'd rather just talk before filling out anything, the email and phone below are the desk's.

Desk
Dallas, Texas
Hours
Mon–Fri · 08:30–18:00 CT
Input · New Inquiry ● accepting
Confidential. Read by the CEO/Founder. Replied to with care.